EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18 F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction

Rebecca Sullivan, Jinqiang Hou, Lihai Yu, Benjamin Wilk, Jane Sykes, Heather Biernaski, John Butler, Michael Kovacs, Justin Hicks, Jonathan D Thiessen, Rohan Dharmakumar, Frank S Prato und 3 weitere

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Rebecca Sullivan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada. Hauptthemen laut MEDLINE: Receptors, Ghrelin, Myocardial Infarction, Positron-Emission Tomography, Fluorine Radioisotopes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GhrelinMyocardial InfarctionPositron-Emission TomographyFluorine RadioisotopesAnimalsDogsLigandsIsotope LabelingDrug DesignMyocardiumRadiochemistryChemistry Techniques, SyntheticQuinazolinonesRadiopharmaceuticals

Stichwörter der Autor:innen

PETcardiacghrelinpreclinicalreceptor

Substanzen

Receptors, GhrelinFluorine RadioisotopesLigandsFluorine-18QuinazolinonesRadiopharmaceuticals

Autor:innen und Institutionen

  • Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.
  • Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
  • Lakehead University and Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada.
  • London Regional Cancer Program, London, Ontario, Canada.
  • Department of Medical Biophysics, Western University, London, Ontario, Canada.
  • Indiana School of Medicine, Indianapolis, Indiana; and.

Zitieren

APA

Sullivan, R., Hou, J., Yu, L., Wilk, B., Sykes, J., Biernaski, H., Butler, J., Kovacs, M., Hicks, J., Thiessen, J. D., Dharmakumar, R., Prato, F. S., Wisenberg, G., Luyt, L. G., & Dhanvantari, S. (2024). Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18 F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267578

Vancouver

Sullivan R, Hou J, Yu L, Wilk B, Sykes J, Biernaski H, et al. Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18 F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267578

BibTeX
@article{Sullivan2024,
  author = {Sullivan, Rebecca and Hou, Jinqiang and Yu, Lihai and Wilk, Benjamin and Sykes, Jane and Biernaski, Heather and Butler, John and Kovacs, Michael and Hicks, Justin and Thiessen, Jonathan D and Dharmakumar, Rohan and Prato, Frank S and Wisenberg, Gerald and Luyt, Leonard G and Dhanvantari, Savita},
  title = {Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18 F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267578}
}
Kostenlos starten →